Liver diseases are commonly diagnosed using serum enzyme assays, particularly for aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), and 5′-nucleotidase (5′-NT).
Ascend Wellness Q3 Revenue Lifts 15% Sequentially
AWH ANNOUNCES Q3 2023 FINANCIAL RESULTS Reported Record Quarterly Revenue for 6th Consecutive Quarter Achieved $141.3M Net Revenue in Q3 2023, a 27.0% Increase Year-Over-Year